GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Daxor Corp (FRA:DX5) » Definitions » Policy Acquisition Expense

Daxor (FRA:DX5) Policy Acquisition Expense


View and export this data going back to 2021. Start your Free Trial

What is Daxor Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Daxor (FRA:DX5) Business Description

Traded in Other Exchanges
Address
109 Meco Lane, Oak Ridge, TN, USA, 37830
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.